live webinar
Advancing CLL Treatment:
Navigating the 1L Landscape & Beyond
International perspectives from ERIC 2026
Thursday 19 November 202619:30 – 21:00Online live webinar
The treatment landscape in CLL is moving fast. The updated EHA guideline and the ERIC 2026 consensus raise practical questions: which molecular tests, at which moment, and how do the recommendations translate to treatment selection in first line and at relapse?
In this live webinar, a European expert panel discusses two patient cases, guided by short videos recorded on site at ERIC 2026 in Barcelona. Live commentary, panel discussion and your questions, with room for the most recent data in the run-up to ASH.
Accreditation: NIV & EBAH (application pending)
Program
Explore two CLL patient cases and how current guidelines shape testing and treatment across Europe.
Opening
Patient case 1: newly diagnosed CLL
EHA guideline update: first-line treatment
Case deep dive and discussion
Patient case 2: relapse after a 1L venetoclax-based combination
EHA guideline update: second-line treatment and sequencing
Case deep dive & panel discussion: treatment selection at relapse
Future outlook
Take-home messages & closing remarks
Speakers
Prof. Arnon Kater, MD, PhD
Hematologist and professor of Translational Hematology, Amsterdam UMC, the Netherlands
Prof. Barbara Eichhorst, MD, PhD
Hematologist/oncologist and professor, University Hospital Cologne, Germany
Dr Talha Munir, MD, PhD
Consultant hematologist, Leeds, United Kingdom
Speaker to be announced
More information coming soon
Register now
Register for the live webinar using the form. You will receive a confirmation by email after registration. Can’t attend live? Register anyway and we will send you access to the on-demand recording after the webinar.